Episode

Author Interview Series SNO Podcast May 2026

Podcast
Neuro-Oncology: The Podcast
Published
May 25, 2026
Duration seconds
983
Processing state
not_requested
Canonical source
https://soc-neuro-onc.libsyn.com/author-interview-series-sno-podcast-may-2026
Audio
https://traffic.libsyn.com/secure/soc-neuro-onc/nop-138B.mp3?dest-id=2339594
JSON
/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/author-interview-series-sno-podcast-may-2026
Markdown
/podcast/neuro-oncology-the-podcast-1565653/author-interview-series-sno-podcast-may-2026.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/author-interview-series-sno-podcast-may-2026/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-series-sno-podcast-may-2026.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Podcast Host and Interviewee: Dr. Haseeb Mehmood Qadri interviews Prof. Dr. Ghazaleh Tabatabai Dr. Haseeb Mehmood Qadri interviews Prof. Dr. Ghazaleh Tabatabai from the Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Germany on their manuscript, entitled Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort